Anzeige
Mehr »
Login
Montag, 29.04.2024 Börsentäglich über 12.000 News von 686 internationalen Medien
Fokus auf Nurexone: High-Level Biotech im Pennystock-Kleid!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
160 Leser
Artikel bewerten:
(0)

Genomma Lab Internacional Acquires Brands Flor de Naranja Sanborns(MR), Teatrical and Henna Egipcia From Grupo Sanborns / These acquisitions reinforce Genomma Lab's presence in the cosmetics and hair product categories and mark the Company's entrance in

MEXICO CITY, June 5 /PRNewswire-FirstCall/ -- Genomma Lab Internacional S.A.B. DE C.V. (BMV: LAB) ("Genomma Lab" or "the Company"), one of the largest and most diversified Mexican companies in the pharmaceutical and personal care products categories, announced the acquisition of the brand of lotions Flor de Naranja Sanborns(MR), the brand properties for Teatrical creams, Henna Egipcia hair color, and a 99 year license for the use of Sanborns(MR) brands from the acquired brands.

With this acquisition, Genomma Lab strengthens its presence in the face cream and body lotions markets as well as hair products categories, while expanding its offering of lotion and perfume products. Sales for the acquired brands reached Ps. 110.3 million during the trailing twelve months ended April 30, 2009.

Teatrical is a traditional and popular brand in Mexico. Registered for sale since 1928, its range of face creams and body lotions has been on the minds of several generations of consumers for over 80 years.

Cologne water Flor de Naranja Sanborns(MR) has an 82-year trajectory and is also one of the most recognized brands in its market segment.

Finally, Henna Egipcia is a recognized brand of discreet hair color products with a nearly 45-year history in the marketplace.

"These acquisitions are in line with the Company's growth strategy implemented since the public offering, which includes the generation and acquisition of new brands and products in order to increase its presence in the medicinal and personal care products markets," stated Mr. Rodrigo Herrera, Chief Executive Officer.

Genomma Lab seeks to revitalize its acquired brands and strengthen its expansion via the application of its business model.

Genomma Lab paid for this transaction with its own resources at a multiple of 2.7x sales for the trailing twelve months for a total of Ps. 300 million, of which approximately 50% will be paid in 10 payments over 10 years.

Company Description

Genomma Lab Internacional, S.A.B. de C.V. is a leading over-the-counter pharmaceuticals and personal care products company in Mexico with international presence. Genomma develops, sells and markets a broad range of premium branded products, many of which are leaders in the categories in which they compete in terms of sales and market share.

The Company is listed on the Mexican Stock Exchange under the ticker symbol "LAB.B" (Bloomberg: labb.mx).

Web Site: http://www.genommalab.com/

Genomma Lab Internacional, S.A.B. de C.V.

CONTACT: Oscar Villalobos, Tel: +52 (55) 5081 0000 Ext. 4250,
inversion@genommalab.com; or in New York: i-advize Corporate Communications,
Inc., Tel: (212) 406-3691/95, genomma@i-advize.com

Web Site: http://www.genommalab.com/

Großer Insider-Report 2024 von Dr. Dennis Riedl
Wenn Insider handeln, sollten Sie aufmerksam werden. In diesem kostenlosen Report erfahren Sie, welche Aktien Sie im Moment im Blick behalten und von welchen Sie lieber die Finger lassen sollten.
Hier klicken
© 2009 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.